Using Ketone Bodies to Treat Alzheimer's Disease
Author Information
Author(s): Costantini Lauren C, Barr Linda J, Vogel Janet L, Henderson Samuel T
Primary Institution: Accera, Inc.
Hypothesis
Can AC-1202 improve cognitive function in Alzheimer's disease by elevating serum ketone levels?
Conclusion
AC-1202 has been shown to improve memory and cognition in patients with mild-to-moderate Alzheimer's disease.
Supporting Evidence
- AC-1202 improved memory and cognition in patients with mild-to-moderate Alzheimer's disease.
- Higher serum BHB levels correlated with better cognitive performance.
- ApoE4-negative patients showed significant improvement compared to ApoE4-positive patients.
Takeaway
This study suggests that a special treatment can help people with Alzheimer's by giving their brains a different kind of fuel to work better.
Methodology
The study involved clinical trials where patients received AC-1202 and their cognitive performance was measured.
Potential Biases
Potential bias due to the authors being employees of the company that manufactures AC-1202.
Limitations
The study had a small sample size and some participants experienced gastrointestinal distress.
Participant Demographics
Participants had a mean age of 74.7 years and included individuals diagnosed with probable Alzheimer's disease or mild cognitive impairment.
Statistical Information
P-Value
0.012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website